menu
    • menu

    Company profile for Helix BioPharma

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Helix BioPharma Corporation is a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology, based on its proprietary technological platform DOS47. Helix is currently listed on TSX and FSE under the symbol “HBP” - Our most innovative technological platform for the treatment of solid tumors.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Helix BioPharmaCanada Flag
    Country
    Country
    Canada
    Address
    Address
    9120 Leslie Street, Suite 205 Richmond Hill, Ontario L4B 3J9
    Telephone
    Telephone
    905.841.2300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.helixbiopharma.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Helix BioPharma to Present at Q3 Investor Summit Virtual
    Helix BioPharma to Present at Q3 Investor Summit Virtual

    09 Sep 2025

    // ACCESSWIRE

    https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/helix-biopharma-announces-presentation-at-q3-investor-summit-virtual-1070747

    ACCESSWIRE
    09 Sep 2025
    Share Share
    QIAGEN and Helix Launch Partnership to Advance Sequencing Companion Diagnostics
    QIAGEN and Helix Launch Partnership to Advance Sequencing Companion Diagnostics

    05 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230105005492/en

    BUSINESSWIRE
    05 Jan 2023
    Share Share
    Blade runs to Wall St. at $353M SPAC deal for 2 trials in 2022
    Blade runs to Wall St. at $353M SPAC deal for 2 trials in 2022

    09 Nov 2021

    // Alex Keown BIOSPACE

    https://www.biospace.com/article/blade-therapeutics-eyes-nasdaq-in-2022-with-planned-spac-merger/

    Alex Keown BIOSPACE
    09 Nov 2021
    Share Share
    FDA ranks the performance of 58 molecular coronavirus tests from developers
    FDA ranks the performance of 58 molecular coronavirus tests from developers

    16 Sep 2020

    // C. Hale FIERCEBIOTECH

    https://www.fiercebiotech.com/medtech/fda-ranks-performance-58-molecular-coronavirus-tests-from-major-developers

    C. Hale FIERCEBIOTECH
    16 Sep 2020
    Share Share
    CAIAC Fund Management AG Acquires Securities of Helix Biopharma Corp.
    CAIAC Fund Management AG Acquires Securities of Helix Biopharma Corp.

    28 Aug 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/08/28/2085641/0/en/CAIAC-Fund-Management-AG-Acquires-Securities-of-Helix-Biopharma-Corp.html

    GLOBENEWSWIRE
    28 Aug 2020
    Share Share
    Helix BioPharma Corp. and Moffitt Cancer Center Extend Immunotherapy Collab
    Helix BioPharma Corp. and Moffitt Cancer Center Extend Immunotherapy Collab

    13 Aug 2020

    // PRESS RELEASE

    https://www.helixbiopharma.com/helix-biopharma-corp-and-moffitt-cancer-center-extend-immunotherapy-collaboration/

    PRESS RELEASE
    13 Aug 2020
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search